相关实验视频

Updated: Jul 26, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.3K

鉴定预测局部晚期直肠癌中对新辅助化学辐射敏感性的枢纽基因

Qunye Zhao1, Chuang Zhang2, Xiaotain Zhang3

  • 11Department of Colorectal Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.

Radiology and oncology
|August 7, 2025
PubMed
概括

需要用于局部晚期直肠癌 (LARC) 对新辅助化学辐射 (NACR) 反应的生物标志物. 六个枢纽基因 (RRM2,HNRNPL,EZH2,METTL1,NHP2L1,ASF1B) 被确定为LARC患者中NACR敏感性的潜在预测因素.

关键词:
生物标志物生物标志物核心基因 核心基因 核心基因局部先进的直肠癌 局部先进的直肠癌新辅助剂的化学辐射敏感性

更多相关视频

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.6K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.6K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...